FDA cracking down on compound GLP-1s?

[Wes19]

FDA is coming down hard.

https://www.fda.gov/drugs/human-drug-compounding/warning-letters-related-compounding

 

[PlateauBuster]

Another one? Or is it the same one from a little while ago?

 

[Wes19]

I think this is a new alert. Clicking the link shows a list of the targeted companies.

 

[PlateauBuster]

Right, I remember something similar last year.

 

[almost-there]

This scares me. I've struggled with my weight for decades, and now that I've found something helpful, the government might step in and take it away. I really hope not.

 

[GeneTale690]

The FDA can't even get some other substances banned fast enough, so I wouldn't sweat this GLP-1 thing too much.

 

[Wes19]

They aren't getting paid to ban that other stuff. It matters when big pharma gets involved.

 

[GeneTale690]

Oh, they're definitely feeling pressure from big pharma on the other stuff too.

 

[FiberTracker]

Ugh, Big Pharma at it again. Leave us alone!

 

[Bio_IMO]

Reading about the FDA stuff makes me nervous. I've been thinking about trying some peptides for muscle growth, but then I read stuff about cancer risks... anyone else worried about this?

 

[Owl_Healed]

I feel you Bio_IMO. I've been looking into Ipamorelin and Mod GRF, but reading about potential long-term effects is giving me pause. Especially lately, I'm trying to be more careful about what I put into my body.

 

[CompoundRoad]

It's wise to be cautious. I worry a bit about topical finasteride absorption, even though it's supposed to be localized. I'm not sure how I feel about the reports of ED and depression even with topical application. Proceed with caution.

 

[FiberTracker]

Proceed with caution.

Absolutely. Always weigh the potential benefits against the risks. Especially with compounded medications, since they don't have the same FDA oversight.

 

[Wes19]

Thanks for the info FiberTracker. I'm going to do some more research before using any of this stuff.

 

[Bobby_2006]

GLP-3PO is probably on a whiteboard somewhere. Reformulations to reset regulatory timelines are not unprecedented, but the FDA tends to close that loop eventually.

 

[spryeasygoing29]

The GLP-3PO rebrand as the regulatory workaround has a certain elegance as a Star Wars reference, even if the actual regulatory pathway is considerably less cinematic.

 

[Curated_Cloud7]

the regulatory capture argument isn't entirely wrong as a diagnosis but it doesn't fully explain the compounding enforcement pattern - the concerns about sterility and concentration accuracy in unregulated compounding operations are real independent of the pharmaceutical industry's financial interest in shutting down competition. both things can be true at the same time